VALENCIA, Calif., Sept. 28, 2016 /PRNewswire/ -- Bioness, Inc. is pleased to announce that Eric Grigsby MD, MBA has joined its leadership team as Chief Medical Officer (CMO). Bioness is the leading provider of cutting edge technologies helping people control pain, regain mobility and improve independence. Dr. Grigsby's experience with pain management will be of particular significance towards advancing Bioness' recently launched StimRouter™ Neuromodulation System, a minimally invasive device specifically designed to treat chronic peripheral pain. This new role will complement his position as Chief Medical Officer at the Alfred Mann Foundation.
"We are thrilled to welcome Dr. Grigsby to Bioness as we continue to ramp our efforts around the StimRouter," said Todd Cushman, Chief Executive Officer of Bioness. "Dr. Grigsby brings a wealth of clinical experience in pain management and has helped develop surgical implants specific to neuromodulation. Only recently introduced, the StimRouter has delivered remarkable patient outcomes. As we expand into new peripheral nerve applications, Dr. Grigsby's experience will help lead Bioness clinical and development initiatives."
With more than 25 years of experience, Dr. Grigsby has been helping patients regain their quality of life through accurate diagnosis and successful treatment programs. He founded the Napa Pain Institute in 1992, one of the oldest and most recognized pain practices in the region where he continues to practice as a board certified Pain Physician. Dr. Grigsby is the former President and Chief Executive Officer of Neurovations, a leading clinical trial management and pain education consulting company. Prior to Neurovations, Dr. Grigsby earned his MBA from Duke University's Fuqua School of Business in 2012 to better understand the evolving business dynamics of the healthcare environment.
Dr. Grigsby graduated from Boston University Medical School in 1984 and went on to train in General Surgery, Anesthesiology and Pain Management at the Mayo Clinic in Rochester, Minnesota. He later joined the Medical Staff of Mayo Medical School and was welcomed as Founding Medical Director of the first pain management center at University of California, Davis Medical Center.
"I am excited to join the Bioness team to help advance our innovations in neuromodulation to aid clinicians and patients better manage chronic pain," said Dr. Grigsby. "While working with the Alfred Mann Foundation, I saw first hand the passion and drive needed to bring novel products that meet unmet medical needs to market. The StimRouter embodies Alfred Mann's vision of improving the lives of people in need through disruptive technology and I am excited to help Bioness achieve that mission with this new device."
About Bioness, Inc.
Bioness is the leading provider of innovative technologies helping people control pain, regain mobility and improve independence. Bioness solutions include external and implantable functional electrical stimulation (FES) systems, robotic systems and software-based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries. Individual results vary. Consult with a qualified physician to determine if this product is right for you. Contraindications, adverse reactions and precautions are available online at www.bioness.com.
StimRouter™ and Bioness® are trademarks of Bioness, Inc. | www.bioness.com | Rx Only
Additional information about StimRouter can be found at www.stimrouter.com.
Next Step Communications
For more information:
Last updated on: 28/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.